InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Levin Mark J, Director. Insider active across 1 company, notably Fulcrum Therapeutics, Inc.. Aggregated, 2 disclosures have been logged. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Mark J. Levin is a Board Member at Fulcrum Therapeutics, Inc. He participates in the governance of the company and strategic decision-making. Mark brings expertise in biotechnology, contributing to innovation and growth at Fulcrum.